Difficulty: Medium
Average Score: 70%
Practice
The following drugs are useful in management of asthma EXCEPT:
Correct answer
B
Rationale
In the context of managing asthma, it is crucial to understand the mechanisms of action of various drugs to make informed treatment decisions. In this scenario, the correct answer is B) Leukotriene. Leukotriene modifiers, such as Montelukast, are indeed useful in managing asthma as they help to reduce inflammation, bronchoconstriction, and mucus production in the airways.
Option A) Montelukast is a leukotriene receptor antagonist and is commonly used in asthma treatment. It helps to prevent asthma symptoms and attacks by blocking the action of leukotrienes.
Option C) Prednisolone is a corticosteroid that is often used in asthma management to reduce inflammation in the airways and prevent asthma exacerbations.
Option D) Ipratropium is an anticholinergic bronchodilator that is more commonly used in conditions like COPD rather than asthma.
Educationally, understanding the specific roles of different medications in asthma management is essential for healthcare providers to tailor treatment plans to individual patients. Knowing which drugs are effective in asthma and which are not helps in optimizing patient care and outcomes. This rationale provides a comprehensive explanation of why each option is either correct or incorrect in the context of managing asthma.
Option A) Montelukast is a leukotriene receptor antagonist and is commonly used in asthma treatment. It helps to prevent asthma symptoms and attacks by blocking the action of leukotrienes.
Option C) Prednisolone is a corticosteroid that is often used in asthma management to reduce inflammation in the airways and prevent asthma exacerbations.
Option D) Ipratropium is an anticholinergic bronchodilator that is more commonly used in conditions like COPD rather than asthma.
Educationally, understanding the specific roles of different medications in asthma management is essential for healthcare providers to tailor treatment plans to individual patients. Knowing which drugs are effective in asthma and which are not helps in optimizing patient care and outcomes. This rationale provides a comprehensive explanation of why each option is either correct or incorrect in the context of managing asthma.